From: Michael-Dyer, Gerri [GDyer@AHRQ.GOV]
Sent: Friday, July 09, 2004 11:38 AM
To: Butler, Jennie -FDA
Cc: Michael-Dyer, Gerri; Colie, Tasha
Subject: Comments for 2004S-0170

Importance: High

Our Exec Sec received these comments directly and we want to have them included in the FDA Dockets system with the rest so it will have a number assigned and be publicly available online as the others are.



Will you be able to enter them in the system for us? Thanks.



Gerri Michael Dyer 
Electronic Dissemination Advisor 
Agency for Healthcare Research and Quality 
Room 2319 Eisenberg Building 
540 Gaither Road 
Rockville, MD 20850 
Phone: 301-427-1898 
Fax: 301-427-1873 
E-mail: gdyer@ahrq.gov 
Web site: http://www.ahrq.gov 

-----Original Message-----

From: CTS_Notifier/AHRQ@Domino1.ahcpr.gov [mailto:CTS_Notifier/AHRQ@Domino1.ahcpr.gov] 

Sent: Wednesday, July 07, 2004 2:34 PM

To: cjoy@ahrq.gov

Cc: mwhite@ahrq.gov

Subject: ExecSec-2004-C-0451(due 07/21/2004) - Controlled Correspondence Notification





A piece of Controlled Correspondence has been received which requires your Office/Center's attention.



The Subject of the Controlled Correspondence (control #

ExecSec-2004-C-0451) is:



Dr. Eugene Sekiguchi et al writes the Dir dtd 7/1/04, regarding Docket I.D.

2004S-0170- Medicare Prescription Drug, Improvement, and Modernization Act of 2003, Section 1013: Suggesting Priority Topics for Research in FY 2006.